CN102512598B - Medicinal composition for arresting bleeding and generating blood platelets - Google Patents
Medicinal composition for arresting bleeding and generating blood platelets Download PDFInfo
- Publication number
- CN102512598B CN102512598B CN2012100028027A CN201210002802A CN102512598B CN 102512598 B CN102512598 B CN 102512598B CN 2012100028027 A CN2012100028027 A CN 2012100028027A CN 201210002802 A CN201210002802 A CN 201210002802A CN 102512598 B CN102512598 B CN 102512598B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal composition
- arresting
- bleeding
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for arresting bleeding. The medicinal composition for arresting bleeding comprises the following components in parts by weight: 50 parts of crinis trachycarpi, 50 parts of garden burnet root, 40 parts of Chinese mugwort leaf, 50 parts of Chinese arborvitae twig, 40 parts of callicarpa undiflora, 40 parts of cogongrass rhizome, 30 parts of common bletilla pseudobulb, 35 parts of crinis ustus, 50 parts of hairyvein agrimonia herb and bud, 40 parts of common cephalanoplos herb, 35 parts of sophora flower, 40 parts of cattail pollen and 30 parts of Chinese atractylodes. A preparation method of the medicinal composition comprises the following steps of: drying the components, and frying the components into carbon with slow fire respectively; mixing and smashing into fine powder; and sieving with a 120-mesh sieve. The medicinal composition has the advantages of remarkable bleeding arresting and blood platelet generating effects, high curative ratio, no side effect and particularly one-time healing curative effect on nosebleed.
Description
Technical field:
The present invention relates to a kind of hemostasis hemopoietic platelet pharmaceutical composition.
Background technology:
Allly can promote blood coagulation and make the medicine of stopped bleeding, be referred to as hemorrhage.It impels blood coagulation, to reach the hemostasis purpose by strengthening body intravascular coagulation factor or suppressing anticoagulant factor.Effects such as the Chinese medicine hemorrhage has convergence, solidifies, clearing heat in YING system, removing heat from blood are in order to treat hemorrhages such as epistaxis blood, thrombocytopenic purpura is hemorrhage.Blood exists blood coagulation and two of anticoagulations to oppose and unified contradiction process in function, and the two complements each other to keep dynamic equilibrium, and blood can constantly be circulated in blood vessel under physiological conditions, also can coagulation take place in the part of damage.
Hemostasis is the important physical function, comprises vasoconstriction, platelet aggregation and three key factors of blood coagulation.As traumatic hemorrhage, see that then local vascular shrinks, platelet is in the coagulation of angiorrhexis place, break and discharge vasoconstrictor substance and reach " thrombin ", and the solid sons of some blood coagulations in tissue fluid and the blood plasma (factor V, VII, VIII, IX, XI, XII etc.) are also activated and participate in the blood clotting process, so clot forms, stopped bleeding.In addition, after fibrin formed, the plasminogen in the blood plasma became plasmin (protease) through activity factor (tissue kinases, urokinase) effect, and fibrin is decomposed, with endovascular clot dissolution, unimpeded to recover regional flow.
Hemostasis is challenge, can be subjected to the influence of many factors, as the various factors of height, blood viscosity and the blood coagulation of the thickness of blood vessel, blood pressure etc., but the most important thing is the various factors of blood coagulation process.
Summary of the invention:
The object of the present invention is to provide a kind of pharmaceutical composition of the hemopoietic platelet that stops blooding, this medicine composite for curing hemostasis hemopoietic platelet effect is obvious, cures height, has no side effect, and particularly treats the once effect of property healing of epistaxis.
The technical solution used in the present invention is: the pharmaceutical composition of this treatment hemostasis comprises following component, and each component is as follows by weight ratio: 50 parts of charred Petiolus Trachycarpi; 50 parts of Radix Sanguisorbaes; 40 parts of Folium Artemisiae Argyis; 50 parts of Cacumen Platycladis; 40 parts of Folium Callicarpae Formosanae; 40 parts of Rhizoma Imperataes; 30 parts of Pseudobulbus Bletillae (Rhizoma Bletillae); 35 parts of Crinis Carbonisatus; 50 parts of Herba Agrimoniaes; 40 parts of Herba Cirsiis; 35 parts in Flos Sophorae; 40 parts of Pollen Typhaes; 30 parts in Radix Rubiae, with after above-mentioned each component drying respectively slow fire fry into carbon, be ground into fine powder after the mixing, cross 120 mesh sieves.
Folium Callicarpae Formosanae, Herba Cirsii have the effect that local vascular is shunk and stop blooding in the such scheme; Herba Agrimoniae, Folium Callicarpae Formosanae act on coagulation process, shorten clotting time, and the effect of platelet increasing number and coagulant is arranged; The Pseudobulbus Bletillae (Rhizoma Bletillae) has the enhancing PF3A, shortens the effect of thromboplastin rise time; Pollen Typhae has the effect that increases thrombin in the blood; Radix Rubiae has the effect of correcting the blood coagulation disorders that heparin causes; Flos Sophorae, Flos Imperatae tool improve the blood vessel wall function, strengthen blood capillary to the resistance of damage, reduce the function of vascular permeability; Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Cirsii, Radix Sanguisorbae, Folium Artemisiae Argyi, Herba Agrimoniae can suppress the activity of plasmin (fibrinolysin); The one side of Radix Rubiae, the existing promotion blood clotting of Pollen Typhae also has the clot dissolution of impelling effect, and this illustrates that it has hemostasis and blood circulation promoting and blood stasis dispelling function concurrently, is conducive to hemostasis and does not stay the stasis of blood.
The invention has the beneficial effects as follows: the effect of drugs of this treatment hemostasis hemopoietic platelet and aplastic anemia is obvious, cures height, short treating period, and safe ready has no side effect.Particularly treat the once effect of property healing of epistaxis.
The specific embodiment:
The invention will be further described below in conjunction with embodiment:
The preparation of drug combination method of this treatment hemostasis hemopoietic platelet:
With ancestor's bone 50 grams, Radix Sanguisorbae 40 grams, Folium Artemisiae Argyi 50 grams, Cacumen Platycladi 50 grams, Folium Callicarpae Formosanae 40 grams; Rhizoma Imperatae 40 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 30 grams, Crinis Carbonisatus 35 grams, Herba Agrimoniae 50 grams, Herba Cirsii 40 grams, Flos Sophorae 35 grams, Pollen Typhae 40 grams, Radix Rubiae 30 grams are used warm water cleaning, sterilization respectively, and 60 degree are dry, are processed into carbon respectively, and mixed powder is broken into fine powder, crosses 120 mesh sieves, and is standby.Package stand-by by 20 gram portions.Adult every day three times, each bag (early, noon, evening each bag); The child takes according to the body weight of self.Each course for the treatment of of stopping blooding is two to three days.The treatment epistaxis is the effect of property healing once.Treatment hemopoietic platelet each course for the treatment of is 20 to 30 days.
The clinical effectiveness statistics of this medicine sees Table 1:
Table 1
Claims (1)
1. a pharmaceutical composition for the treatment of hemostasis comprises following component, and each component is as follows by weight ratio: 50 parts of charred Petiolus Trachycarpi; 50 parts of Radix Sanguisorbaes; 40 parts of Folium Artemisiae Argyis; 50 parts of Cacumen Platycladis; 40 parts of Folium Callicarpae Formosanae; 40 parts of Rhizoma Imperataes; 30 parts of Pseudobulbus Bletillae (Rhizoma Bletillae); 35 parts of Crinis Carbonisatus; 50 parts of Herba Agrimoniaes; 40 parts of Herba Cirsiis; 35 parts in Flos Sophorae; 40 parts of Pollen Typhaes; 30 parts in Radix Rubiae, with after above-mentioned each component drying respectively slow fire fry into carbon, be ground into fine powder after the mixing, cross 120 mesh sieves.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100028027A CN102512598B (en) | 2012-01-06 | 2012-01-06 | Medicinal composition for arresting bleeding and generating blood platelets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100028027A CN102512598B (en) | 2012-01-06 | 2012-01-06 | Medicinal composition for arresting bleeding and generating blood platelets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512598A CN102512598A (en) | 2012-06-27 |
| CN102512598B true CN102512598B (en) | 2013-08-14 |
Family
ID=46283850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100028027A Expired - Fee Related CN102512598B (en) | 2012-01-06 | 2012-01-06 | Medicinal composition for arresting bleeding and generating blood platelets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512598B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816345A (en) * | 2012-11-19 | 2014-05-28 | 董根荣 | Medicament for treating traumatic injury and preparation method thereof |
| CN103393980A (en) * | 2013-08-22 | 2013-11-20 | 常熟华港制药有限公司 | Quick and effective hemostasis traditional Chinese medicine tincture |
| CN104161995A (en) * | 2014-08-25 | 2014-11-26 | 河南科技大学第一附属医院 | Bleeding stopping and blood coagulating powder used for traumatic hemorrhage and preparation method thereof |
| CN104173812A (en) * | 2014-09-04 | 2014-12-03 | 纪雪梅 | Pharmaceutical composition for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura and preparation method of pharmaceutical composition |
| CN104367818A (en) * | 2014-10-22 | 2015-02-25 | 吴杰 | Traditional Chinese medicine preparation for treating hemophilia |
| CN104383342A (en) * | 2014-12-08 | 2015-03-04 | 吕凤荣 | Traditional Chinese medicine preparation for treating aplastic anemia complicated by epistaxis disease |
| CN106551341A (en) * | 2015-09-16 | 2017-04-05 | 哈尔滨灵椿味道食品开发有限公司 | A kind of Herba Cirsii cooling blood for hemostasis soup stock and preparation method thereof |
| CN105477421A (en) * | 2015-12-17 | 2016-04-13 | 青岛市市立医院 | Pharmaceutical composition for preventing and treating thrombocytopenia after radiotherapy and application of pharmaceutical composition |
| CN107737256A (en) * | 2017-10-20 | 2018-02-27 | 张翠玲 | A kind of ointment with hemostatic function and preparation method thereof |
| CN109125790A (en) * | 2018-08-25 | 2019-01-04 | 山东康力医疗器械科技有限公司 | A kind of styptic sponge structure made of chitosan |
| CN111529632A (en) * | 2020-05-18 | 2020-08-14 | 蔡建华 | Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof |
| CN113855814A (en) * | 2020-06-12 | 2021-12-31 | 徐家祥 | Medicinal composition with hemostatic function |
| CN113797352A (en) * | 2020-06-12 | 2021-12-17 | 徐家祥 | Preparation method of medicinal composition with hemostatic function |
| CN113171433A (en) * | 2021-06-09 | 2021-07-27 | 武汉市帆成丰硕生物科技有限公司 | Chinese medicinal composition preparation |
| CN114652516A (en) * | 2022-03-28 | 2022-06-24 | 左点健康产业(深圳)有限公司 | Expansion type pressurizing band-aid for hemostasis |
-
2012
- 2012-01-06 CN CN2012100028027A patent/CN102512598B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 何希瑞，等.常用止血中药及其止血机制研究进展.《中国实验方剂学杂志》.2010,第16卷(第15期),第217-221页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512598A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512598B (en) | Medicinal composition for arresting bleeding and generating blood platelets | |
| EP2654764B1 (en) | Hemostatic preparation containing an extract of golden moss | |
| CN103055102B (en) | Traditional Chinese medicine used for stopping bleeding, relieving pain and promoting tissue regeneration of wound | |
| CN103948774A (en) | Traditional Chinese medicine solution for internal fistula care and preparation method thereof | |
| CN105288710A (en) | Medical bandage capable of arresting bleeding and regenerating tissue and production method thereof | |
| CN105617181A (en) | Externally applied anti-inflammatory and bactericidal traditional Chinese medicine | |
| CN102973819A (en) | Traditional Chinese medicine prescription for treatment of allergic purpura | |
| CN102247504B (en) | Method for preparing wart eliminating powder | |
| CN105330884A (en) | Preparation method for Chinese herbal medicine latex foam product | |
| CN1051236C (en) | Styptic powder | |
| CN105561382A (en) | Dendrobium officinale liquid woundplast and preparation method thereof | |
| CN103316015B (en) | Medicine for treating epistaxis through oral administration and external use and method thereof | |
| CN102988815B (en) | Health-care medicinal tea for effectively treating nephritis and a preparation method thereof | |
| CN102068676A (en) | Medicament for treating chilblain | |
| CN101513504A (en) | Chinese herbal medicine for remedying thrombocytopenia after radiochemotherapy | |
| CN103006945B (en) | Multifunctional medicinal liquor for external use | |
| CN101791390B (en) | Traditional Chinese medicine compound composition for treating sequelae of cerebral infarction and cerebral hemorrhage and processing method thereof | |
| CN1291746C (en) | Chinese medicine preparation for treating hematophilia | |
| CN105582385A (en) | Traditional Chinese medicine composition for arresting bleeding | |
| CN107375913A (en) | A kind of thrombus dredging collateral medicine for loading Nattokinase and preparation method thereof | |
| CN104474339A (en) | Traditional Chinese medicine for treating thrombus and preparation method of traditional Chinese medicine | |
| CN103536846A (en) | Black powder in southern shaanxi | |
| CN105434512A (en) | Leech mixed powder electuary for treating cardiac and cerebral thrombotic diseases | |
| CN104274772A (en) | External ointment for treating chilblain | |
| CN103860614A (en) | Chinese medicinal preparation for rapid bone setting and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 214192 Jiangsu city in Wuxi Province Economic Development Zone Xishan Furong Road No. 99 three six 3 floor zuiun Patentee after: Ma Yongbo Address before: 150001 Heilongjiang city of Harbin province Liuhe Wuchang Lalin area before building fifth as well as the Doctor Clinic Patentee before: Ma Yongbo |
|
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 150001 Heilongjiang city of Harbin province Liuhe Wuchang Lalin area before building fifth as well as the Doctor Clinic Patentee after: Ma Yongbo Address before: 214192 Jiangsu city in Wuxi Province Economic Development Zone Xishan Furong Road No. 99 three six 3 floor zuiun Patentee before: Ma Yongbo |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130814 Termination date: 20170106 |